Evidence map›Paper›PMID 39933788›Full record

ArticleNanomedicine (London, England)2025

C

Yuriy Prylutskyy, Dmytro Nozdrenko, Olexandr Motuziuk, Svitlana Prylutska, Igor Vareniuk, Natalia Nurishchenko, Daria Franskevych, Vasil Soroсa, Kateryna Bogutska, Uwe Ritter

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Effects of Water-Soluble CMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuriy PrylutskyyESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0002-9847-4137
Dmytro NozdrenkoESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0001-7254-1533
Olexandr MotuziukESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0002-1520-0721
Svitlana PrylutskaFaculty of Plant Protection, Biotechnology and Ecology, National University of Life and Environmental Science of Ukraine, Kyiv, Ukraine.ORCID 0000-0001-5280-8341
Igor VareniukESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0002-9881-5536
Natalia NurishchenkoESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0001-8160-8832
Daria FranskevychESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0002-1719-0512
Vasil SoroсaESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0002-8340-7636
Kateryna BogutskaESC "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.ORCID 0000-0003-0202-8042
Uwe RitterInstitute of Chemistry and Biotechnology, Technical University of Ilmenau, Ilmenau, Germany.ORCID 0000-0002-9315-4863

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe remarkable antioxidant capabilities of biocompatible and safe C

methodsTensometry was used to investigate the biomechanical parameters of muscle contraction, specifically the times of reaching and holding the maximum force response of the muscle, and the return of muscle contraction force to the initial value after cessation of stimulation. Blood biochemical indicators were assessed, including concentrations of c-reactive protein, lactate, creatinine, and reduced glutathione, as well as superoxide dismutase and catalase activities 5, 10, and 15 days after initiating open muscle injury. Histopathological analysis was also performed to examine the rat

resultsIt was found that C

conclusionThese findings suggest using of carbon nanoparticles to correct pathological conditions that may occur during the physiological repair of damaged muscle tissues.

Indexed as

FullerenesMuscle, SkeletalAnimalsAntioxidantsMaleMuscle ContractionNanoparticlesRatsRats, WistarSuperoxide DismutaseAntioxidantsfullerene C60FullerenesSuperoxide Dismutasebiochemical indicators of bloodbiomechanical parameters of muscle contractionC60 fullerenehistopathological analysismuscle gastrocnemiusopen muscle injury

Identifiers

PMID39933788
PMCPMC11881861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.